Continuous Bioprocessing Technologies Market - Global Forecast 2026-2031 | Market to Reach USD 8.5 Billion as Automation and Biologics Demand Fuel 12.1% CAGR

The global continuous bioprocessing technologies market is projected to grow from USD 4.8 billion in 2026 to USD 8.5 billion by 2031, driven by rising biologics demand, regulatory support, and the biopharmaceutical industry's shift from batch to continuous production. Key growth drivers include cost efficiency, improved quality, and faster time to market, though high capital investment and technical complexity remain challenges.

10/01/2026, 11:00 AM • GlobeNewswire

Hummingbird Bioscience Announces First Patient Dosed in Phase II Trial of HMBD-001 and Cetuximab in Advanced Squamous Cell Cancers

Hummingbird Bioscience announced that HMBD-001, an anti-HER3 monoclonal antibody developed using its AI Molecular Medicine platform, has advanced into Phase II clinical trials for advanced squamous cell cancers in combination with cetuximab. The first patient has been dosed in the HMBD-001-103 study, with recommended doses identified based on safety, tolerability, and preliminary efficacy data. The advancement demonstrates the company's AI-first approach to drug discovery and development.

09/30/2026, 5:00 AM • GlobeNewswire

Magnetic Bead Purification Kits Market Outlook 2026-2030: Investment Trends, Strategic Profiles and Revenue Share Outlook

The global magnetic bead purification kits market reached $4.08 billion in 2025 with an 11.6% CAGR and is projected to grow to $6.73 billion by 2030 (10.5% CAGR) and $10.42 billion by 2035 (9.1% CAGR). Growth is driven by expanding genomics research, molecular diagnostics, and high-throughput screening. Semi-automated kits dominate at 51.8% market share, while Asia-Pacific is the fastest-growing region at 12% CAGR. Key challenges include skilled labor shortages and automation infrastructure dependencies.

09/21/2026, 4:56 AM • GlobeNewswire

Autoimmune Disease Therapeutics Market Set for Growth Through 2034 as Biologics, Precision Medicine and Pipeline Innovation Reshape the Competitive Landscape

The global autoimmune disease therapeutics market is projected to grow from USD 132.75 billion in 2025 to USD 254.60 billion by 2034, at a CAGR of 7.5%. Growth is driven by rising autoimmune disease diagnoses, increased adoption of biologics and targeted oral therapies, biosimilar expansion, and emerging cell and gene therapies. Biologics dominate with 66% market share, TNF inhibitors lead drug classes at 29%, and rheumatoid arthritis accounts for 34% of revenue. North America holds 44% regional share while Asia-Pacific is expected to grow fastest.

09/17/2026, 6:49 AM • GlobeNewswire

Bioprocess Automation Market Poised for Robust Growth Through 2033, Driven by Demand for Efficient, Scalable Biomanufacturing

The global bioprocess automation market is projected to grow from USD 8.6 billion in 2025 to USD 22.2 billion by 2033, expanding at a CAGR of 12.8%. Growth is driven by rising demand for biologics, advances in AI and robotics, and pressure to improve manufacturing efficiency and regulatory compliance. Automation technologies enhance throughput, consistency, and cost-effectiveness while reducing errors and production time.

09/15/2026, 5:57 AM • GlobeNewswire

Correction: Bioprinting Market to Reach $5.1 Billion by 2030, Driven by Regenerative Medicine Demand and AI Integration

The global bioprinting market is projected to grow from $2.1 billion in 2024 to $5.1 billion by 2030 at a 16.1% CAGR, driven by regenerative medicine demand, pharmaceutical adoption for drug discovery, reduced animal testing, and AI integration. North America leads with 38% market share, while emerging technologies like 4D bioprinting and organ-on-chip devices expand market boundaries.

08/27/2026, 7:51 AM • GlobeNewswire

[Latest] Global gRNA Market Size/Share Worth USD 2950 Million by 2034 at a 19% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

The global gRNA (guide RNA) market is projected to grow from USD 518 million in 2024 to USD 2,950 million by 2034, representing a 19% CAGR. Growth is driven by increasing cancer research, infectious disease prevalence, technological innovation, and expanding applications in genome editing, functional genomics, diagnostics, cell & gene therapy, and agricultural biotechnology. Key market players include Thermo Fisher Scientific, Agilent Technologies, Merck KGaA, and others. Strategic partnerships and rising adoption of CRISPR technology in agriculture are major growth catalysts.

08/06/2026, 5:30 PM • GlobeNewswire

[Latest] Global Deep Eutectic Solvents Market Size/Share Worth USD 735.89 Million by 2034 at a 15.27% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

The global Deep Eutectic Solvents (DES) market is projected to grow from USD 177.64 million in 2024 to USD 735.89 million by 2034, at a CAGR of 15.27%. Growth is driven by increasing demand for sustainable, eco-friendly alternatives to conventional solvents across pharmaceuticals, food processing, and chemical industries. Key players include Proionic GmbH, Merck KGaA, BASF SE, Thermo Fisher Scientific, and Solvay S.A.

08/05/2026, 3:30 PM • GlobeNewswire

Pyridine & Pyridine Derivatives Market Size to Reach USD 1,255.74 Million by 2035 on Rising Agrochemical and Pharma Demand | SNS Insider

The global Pyridine & Pyridine Derivatives Market is projected to grow from USD 812.04 million in 2025 to USD 1,255.74 million by 2035, at a CAGR of 4.97%. Growth is driven by increasing demand from agrochemical and pharmaceutical industries, with pyridine leading product segments and herbicides dominating applications. Asia Pacific holds the largest market share at 48%, while the U.S. market is expected to reach USD 228.10 million by 2035.

07/23/2026, 6:47 AM • GlobeNewswire

Antiparasitic Drugs Market Report Released — Examines Antimalarials, Anthelmintics, Antiprotozoals, Ectoparasiticides, and Neglected Tropical Disease Therapies

The global antiparasitic drugs market is projected to grow from USD 23.30 billion in 2026 to USD 30.98 billion by 2032 at a 4.88% CAGR. Growth is driven by persistent parasitic disease burden, drug resistance, climate-sensitive vector transmission, and public health programs. Key opportunities include resistance-ready combination therapies, pediatric formulations, AI-enabled discovery, and diagnostics-linked prescribing, with Africa and Asia-Pacific leading endemic demand.

07/20/2026, 11:52 AM • GlobeNewswire

Generative AI in Drug Discovery: Revolutionizing Pharmaceutical Research and Development

The generative AI in drug discovery market is experiencing significant expansion, growing from $0.25 billion in 2025 to $0.33 billion in 2026, with projections to reach $0.86 billion by 2030 at a 27% CAGR. Key drivers include rising drug development costs, computational chemistry advancements, increased biological datasets, and strategic collaborations between AI firms and pharmaceutical companies. Major players are leveraging AI-driven tools for molecule generation, deep learning in drug design, and accelerated early-stage development.

07/10/2026, 10:55 AM • GlobeNewswire

Molecular Biology Enzymes, Reagents and Kits Market Size Worth USD 70.85 Billion by 2035 | SNS Insider

The global molecular biology enzymes, reagents and kits market is projected to grow from USD 27.69 billion in 2025 to USD 70.85 billion by 2035, with a CAGR of 9.68%. Growth is driven by increasing adoption of precision medicine, molecular diagnostics, genomics research, and biotechnology R&D. The US market is expected to reach $23.54 billion and Europe $19.32 billion by 2035, with Asia-Pacific showing the fastest growth.

07/03/2026, 6:48 AM • GlobeNewswire

Global Single-use Bioreactors Market Forecast to Surge from USD 3.61 Billion in 2025 to USD 15.11 Billion by 2034

The global single-use bioreactors market is projected to experience robust growth with a CAGR of 17.27%, expanding from USD 3.61 billion in 2025 to USD 15.11 billion by 2034. Growth is driven by increasing biopharmaceutical demand, cost efficiency advantages, and technological advancements in bioprocessing. North America is expected to dominate, while Asia-Pacific shows rapid expansion. Major players include Sartorius, Thermo Fisher Scientific, and Cytiva, with recent developments including new product launches and facility expansions.

07/03/2026, 5:12 AM • GlobeNewswire

Global Pharmaceutical Filtration Market to Double by 2034: Insights on Driving Factors

The global pharmaceutical filtration market is expected to grow at a CAGR of 8.13% from 2025 to 2034, driven by rising biopharmaceutical demand, CDMO expansion, and increased sterile drug manufacturing. North America leads the market, while Asia-Pacific emerges as a rapidly growing region. Major players are investing in capacity expansion and acquisitions to meet growing demand, though high operational costs and filter clogging challenges persist.

07/03/2026, 4:43 AM • GlobeNewswire

Global Sterile Bioprocess Filtration Market Set to Surge, Projected to Reach USD 31.33 Billion by 2034

The global sterile bioprocess filtration market is projected to grow from USD 6.50 billion in 2025 to USD 31.33 billion by 2034, at a CAGR of 19.13%. Growth is driven by rising biopharmaceutical and vaccine demand, outsourcing to CMOs/CDMOs, and technological advancements. North America is expected to lead the market, with membrane filters dominating the product segment.

07/03/2026, 4:42 AM • GlobeNewswire